my account
  Loading... Please wait...

Product Details

CT-2584 | Inhibitor of CTP: choline-phosphate cytidylyltransferase

CT-2584 (166981-13-1; free base) is a cytotoxic agent that alters phospholipid biosynthesis via inhibition of CTP:choline-phosphate cytidylyltransferase causing an increase in phosphatidylinositol with decreasing levels of phosphatidylcholine.1 The altered phospholipid metabolism caused by CT-2584 results in a loss of lamellar structure and membrane integrity (especially in mitochondria and endoplasmic reticulum). CT-2584 was active against a wide range of tumor cell lines including multi-drug resistant lines.2

1) Finney et al. (2000), Pharmacolgical Inhibition of Phosphatidylcholine Biosynthesis is Associated with Induction of Phosphatidylinositol Accumulation and Cytolysis of Neoplastic Cell lines; Cancer Res., 60 5204
2) Cheeseman et al. (2000), Phase I and pharmacologic study of CT-2584 HMS, a modulator of phosphatidic acid, in adult patients with solid tumors; Br. J. Cancer, 83 1599

Image 1

Catalog#  10-4560

Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee.
Request Bulk Quote
166981-13-1 (free base)
Catalog Number:
Inhibitor of CTP: choline-phosphate cytidylyltransferase
Chemical Name:
1-(11-Dodecylamino-10-hydroxyundecyl)-3,7-dimethylxanthine methane sulfonate
Molecular Weight:
Molecular Formula:
C30H55N5O3 CH3SO3H
Soluble in DMSO (up to 25 mg/ml).
Physical Properties:
White solid
98% by TLC
NMR (Conforms)
Storage Temperature:
Stable for 1 year as supplied.
Shipping Code:
Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications.

Share Focus

Connect with Focus

Click the button below to add the CT-2584 | Inhibitor of CTP: choline-phosphate cytidylyltransferase to your wish list.